New hope for Tough-to-Treat adrenal cancer
NCT ID NCT05036434
Summary
This study is testing whether a combination of two drugs, pembrolizumab (given by IV) and lenvatinib (taken as a pill), can help control advanced adrenal cancer that has continued to grow despite standard chemotherapy. It will involve about 30 adult patients who have already tried other treatments. The main goal is to see if this new combination can shrink tumors or stop them from growing further.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENOCORTICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center
Goyang-si, Gyeonggi-do, 10408, South Korea
Conditions
Explore the condition pages connected to this study.